header-logo
Staff Collaborate Conference Room
Jeffrey Binder, MD
Jeffrey R. Binder, MD

Jeffrey R. Binder, MD

Professor of Neurology, Cell Biology, Neurobiology and Anatomy, and Biophysics; Director of Stroke and Neurobehavior Programs, Department of Neurology; Director of Language Imaging Laboratory, Department of Neurology

Locations

  • Medical College of Wisconsin
    Department of Neurology

Contact Information

Education

MD, University of Nebraska College of Medicine, Omaha, NE, 1986

Biography

Residency, Internal Medicine, Northwestern University Medical School, Chicago, IL, 1987
Resident, Neurology, The Neurological Institute of New York, Presbyterian Hospital; New York, NY, 1987-1990
Fellow, Stroke and Behavioral Neurology, The Neurological Institute of New York, Presbyterian Hospital; New York, NY, 1990-1992

Societies
American Academy of Neurology, 1987
American Association for the Advancement of Science, 1993
International Society for Magnetic Resonance in Medicine, 1995
Society for Neuroscience, 1995
World Federation of Neurology - Research Group on Aphasia and Cognitive Disorders, 1996
Cognitive Neuroscience Society, 1997

Honors and Awards

Graduation with High Distinction, University of Nebraska, 1980
Phi Beta Kappa, 1980
Regents Scholarship, University of Nebraska Medical Center, 1983
Michaelson Student Research Grant, University of Nebraska Medical Center, 1985
Alpha Omega Alpha, 1985

Research Interests

"Functional Magnetic Resonance Imaging of the Brain," NIMH P01 MH51358-01A1 (Co-Investigator).

"Functional MRI of Human Brain Language Systems," NINDS RO1 NS33576-06 (J.R. Binder, P.I.).

"Functional Magnetic Resonance Imaging During Auditory Language Processing," McDonnell-Pew Program in Cognitive Neuroscience, Grant No. 92-35. Total Direct Costs (1993-1995). 20% effort; Principal Investigator.

"Effects of Stimulus Rate, Intensity, and Duration on Functional Magnetic Resonance Signal Response," Medical College of Wisconsin Research Affairs Committee, Grant No. 1093-11. Total funding. Principal Investigator.

"Natural History of Neurobehavioral Dysfunction in MS," National Multiple Sclerosis Society Grant (S.M. Rao, P.I.). Total Direct Costs (1994-1997). 5% effort; Co-Investigator.

"Pre-surgical Localization of Language and Memory Cortex with Functional MRI," Charles A. Dana Foundation Clinical Hypotheses in Neuroscience Research Program. Direct Costs (1994-1997). 14% effort; Principal Investigator.

"A Multicenter, Double-Blind, Placebo-Controlled, Dose-Finding Efficacy Study of CNS 1102 in Patients with Acute Cerebral Ischemia," Cambridge Neuroscience, Inc. Total local costs (1995). 5% effort; Local Principal Investigator.

"Phase II/III Multicenter, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Two Doses of Intravenous Aptiganel Hydrochloride versus Placebo in Patients with Acute Ischemic Stroke," Boehringer Ingelheim, Inc. Total local costs (1996-1997). 5% effort; Local Principal Investigator.

"Clomethiazole Acute Stroke Study (CLASS-I, II, III)," Astra Pharmaceuticals, Inc. (Co-Investigator).

Specialties and Subspecialties

Adult Neurology
Aphasia
Behavioral Neurology
Cerebrovascular Disease
Neuroimaging
Neuropsychology

Publications

Publications of Jeffrey R. Binder MD from the Faculty Collaboration Database

© 2024 Medical College of Wisconsin.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The Medical College of Wisconsin (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.